Hemorrhage remains the leading cause of potentially preventable early trauma-related mortality. To help treat hemorrhage, tranexamic acid (TXA) is an inexpensive option whose optimal use continues to be clarified.
Marilyn J. Heine, MD, FACEP, FACP, clinical assistant professor of medicine at Drexel University College of Medicine in Philadelphia and an emergency physician and hematologist in Dresher, Pennsylvania, will discuss emergency medicine applications of TXA in her presentation.
“Tranexamic acid is being administered in an effort to decrease trauma-associated hemorrhage and/or mortality. The major studies that propelled its use in trauma care were performed predominantly in low/moderate resource countries…Benefit was associated with early TXA infusion. Studies are ongoing to clarify its optimal role in mature trauma systems with a civilian population, such as in the United States,” Dr. Heine said.